Tapewire

NYSE · USD

BMY

BRISTOL MYERS SQUIBB CO

Export transactions ↓
Tapewire entity
1662
SEC CIK
0000014272
Parsed reports
2,253

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2020 Filed Sep 2, 2020 20:33 UTC
Santiago Karen MurphySVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 642 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000238 · wf-form4_159907876937346.xml · nonDerivative · entry 1

Santiago Karen Murphy · CIK 0001732137 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of restricted stock units granted on September 1, 2016.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:33 UTC GrantDeferred Share Units · Derivative 1,306.279 $60.97 $79,643.83
Disclosure

SEC source: 0000014272-20-000240 · wf-form4_159907880683474.xml · derivative · entry 1

Price Paula A · CIK 0001369240 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,306.279

Underlying: Common Stock, $0.10 par value · 1,306.279 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · shares: Represents pro rata portion of the 2020 annual Deferred Share Unit awards granted to the Company's directors.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:34 UTC
Caforio GiovanniDirector · Chairman and CEO
SaleCommon Stock, $0.10 par value 39,840 $62.70 $2,497,968.00
Disclosure

SEC source: 0000014272-20-000241 · wf-form4_159907884066675.xml · nonDerivative · entry 1

Caforio Giovanni · CIK 0001533201 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 445,584.333

F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.68 to $62.75, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
August 17, 2020 Filed Aug 19, 2020 22:15 UTC
Eid JosephSVP,Head Glob. Medical Affairs
SaleCommon Stock, $0.10 par value 5,327 $64.00 $340,928.00
Disclosure

SEC source: 0000014272-20-000233 · wf-form4_159787532506693.xml · nonDerivative · entry 1

Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,534

Read SEC document
August 13, 2020 Filed Aug 17, 2020 20:55 UTC
LEUNG SANDRAEVP, General Counsel
SaleCommon Stock, $0.10 par value 141,420 $63.24 $8,943,400.80
Disclosure

SEC source: 0000014272-20-000231 · wf-form4_159769769257253.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 432,744.333

F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.92 to $63.58, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 20:43 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 46,402 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · derivative · entry 4

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,403

Underlying: Common Stock, $0.10 par value · 46,402 shares

Expires 2021-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 20:43 UTC
Elkins David VEVP, Chief Financial Officer
Tax withholdingCommon Stock, $0.10 par value 25,916 $58.66 $1,520,232.56
Disclosure

SEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · nonDerivative · entry 2

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,782

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
August 01, 2020 Filed Aug 4, 2020 20:43 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionCommon Stock, $0.10 par value 46,402 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · nonDerivative · entry 1

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:54 UTC
Santiago Karen MurphySVP & Controller
Exercise / conversionRestricted Stock Units · Derivative 1,069 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · derivative · entry 3

Santiago Karen Murphy · CIK 0001732137 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,208

Underlying: Common Stock, $0.10 par value · 1,069 shares

Expires 2023-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

F1 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:54 UTC
Santiago Karen MurphySVP & Controller
Tax withholdingCommon Stock, $0.10 par value 367 $59.43 $21,810.81
Disclosure

SEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · nonDerivative · entry 2

Santiago Karen Murphy · CIK 0001732137 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,748

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:54 UTC
Santiago Karen MurphySVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 1,069 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · nonDerivative · entry 1

Santiago Karen Murphy · CIK 0001732137 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:56 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionRestricted Stock Units · Derivative 9,356 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · derivative · entry 3

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,069

Underlying: Common Stock, $0.10 par value · 9,356 shares

Expires 2023-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

F1 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:56 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Tax withholdingCommon Stock, $0.10 par value 4,463 $59.43 $265,236.09
Disclosure

SEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · nonDerivative · entry 2

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,893

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:56 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionCommon Stock, $0.10 par value 9,356 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · nonDerivative · entry 1

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,356

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock units vest in four equal annual installments beginning on July 1, 2020.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:57 UTC GrantDeferred Share Units · Derivative 616.497 $58.80 $36,250.02
Disclosure

SEC source: 0000014272-20-000212 · wf-form4_159372340624194.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,667.561

Underlying: Common Stock, $0.10 par value · 616.497 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:58 UTC GrantDeferred Share Units · Derivative 392.432 $58.80 $23,075.00
Disclosure

SEC source: 0000014272-20-000213 · wf-form4_159372347744271.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,639.199

Underlying: Common Stock, $0.10 par value · 392.432 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:00 UTC GrantDeferred Share Units · Derivative 595.238 $58.80 $34,999.99
Disclosure

SEC source: 0000014272-20-000214 · wf-form4_159372355114736.xml · derivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,384.859

Underlying: Common Stock, $0.10 par value · 595.238 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:02 UTC GrantDeferred Share Units · Derivative 616.497 $58.80 $36,250.02
Disclosure

SEC source: 0000014272-20-000215 · wf-form4_159372365790382.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,664.192

Underlying: Common Stock, $0.10 par value · 616.497 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:05 UTC GrantDeferred Share Units · Derivative 659.014 $58.50 $38,552.32
Disclosure

SEC source: 0000014272-20-000216 · wf-form4_159372387823604.xml · derivative · entry 1

Paliwal Dinesh C · CIK 0001360224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,743.632

Underlying: Common Stock, $0.10 par value · 659.014 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:05 UTC
LACY ALAN JDirector
GrantDeferred Share Units · Derivative 212.585 $58.80 $12,500.00
Disclosure

SEC source: 0000014272-20-000217 · wf-form4_159372391667741.xml · derivative · entry 1

LACY ALAN J · CIK 0001200232 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,952.187

Underlying: Common Stock, $0.10 par value · 212.585 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:07 UTC GrantDeferred Share Units · Derivative 528.893 $58.80 $31,098.91
Disclosure

SEC source: 0000014272-20-000218 · wf-form4_159372397567975.xml · derivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,930.548

Underlying: Common Stock, $0.10 par value · 528.893 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:08 UTC GrantDeferred Share Units · Derivative 114.469 $58.80 $6,730.78
Disclosure

SEC source: 0000014272-20-000219 · wf-form4_159372408446045.xml · derivative · entry 1

GROBSTEIN MICHAEL · CIK 0001222342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,898.191

Underlying: Common Stock, $0.10 par value · 114.469 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:11 UTC GrantDeferred Share Units · Derivative 488.946 $58.80 $28,750.02
Disclosure

SEC source: 0000014272-20-000220 · wf-form4_159372425107000.xml · derivative · entry 1

YALE PHYLLIS R · CIK 0001269070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890.601

Underlying: Common Stock, $0.10 par value · 488.946 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:14 UTC GrantDeferred Share Units · Derivative 579.353 $58.80 $34,065.96
Disclosure

SEC source: 0000014272-20-000222 · wf-form4_159372439003181.xml · derivative · entry 1

Storch Gerald L · CIK 0001205004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,606.059

Underlying: Common Stock, $0.10 par value · 579.353 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:13 UTC GrantDeferred Share Units · Derivative 164.753 $58.80 $9,687.48
Disclosure

SEC source: 0000014272-20-000221 · wf-form4_159372432639233.xml · derivative · entry 1

Vousden Karen H · CIK 0001723884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,077.3

Underlying: Common Stock, $0.10 par value · 164.753 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:15 UTC GrantDeferred Share Units · Derivative 552.721 $58.80 $32,499.99
Disclosure

SEC source: 0000014272-20-000223 · wf-form4_159372446637977.xml · derivative · entry 1

Samuels Theodore R. II · CIK 0001688276 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,049.36

Underlying: Common Stock, $0.10 par value · 552.721 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:15 UTC PurchaseCommon Stock, $0.10 par value 9,174 $54.50 $499,983.00
Disclosure

SEC source: 0000014272-20-000193 · wf-form4_159234210804505.xml · nonDerivative · entry 1

Paliwal Dinesh C · CIK 0001360224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,109.35

Read SEC document
June 14, 2020 Filed Jun 16, 2020 21:15 UTC Exercise / conversionRestricted Stock Units · Derivative 558 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · derivative · entry 4

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 558 shares

Expires 2020-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F3 · shares: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F3 · derivative.exercise_date: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F3 · derivative.expiration_date: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

Read SEC document
June 14, 2020 Filed Jun 16, 2020 21:15 UTC Exercise / conversionCommon Stock, $0.10 par value 558 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · nonDerivative · entry 2

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 14, 2020 Filed Jun 16, 2020 21:16 UTC Exercise / conversionRestricted Stock Units · Derivative 558 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · derivative · entry 5

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 558 shares

Expires 2020-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F3 · shares: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F3 · derivative.exercise_date: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F3 · derivative.expiration_date: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

Read SEC document
June 14, 2020 Filed Jun 16, 2020 21:16 UTC Exercise / conversionCommon Stock, $0.10 par value 558 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · nonDerivative · entry 2

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 13, 2020 Filed Jun 16, 2020 21:15 UTC Exercise / conversionRestricted Stock Units · Derivative 903 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · derivative · entry 3

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 902

Underlying: Common Stock, $0.10 par value · 903 shares

Expires 2021-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F1 · derivative.exercise_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F1 · derivative.expiration_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

Read SEC document
June 13, 2020 Filed Jun 16, 2020 21:15 UTC Exercise / conversionCommon Stock, $0.10 par value 903 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · nonDerivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 13, 2020 Filed Jun 16, 2020 21:16 UTC Exercise / conversionRestricted Stock Units · Derivative 903 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · derivative · entry 4

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 902

Underlying: Common Stock, $0.10 par value · 903 shares

Expires 2021-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F1 · derivative.exercise_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F1 · derivative.expiration_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

Read SEC document
June 13, 2020 Filed Jun 16, 2020 21:16 UTC Exercise / conversionCommon Stock, $0.10 par value 903 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · nonDerivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,092

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:39 UTC Exercise / conversionRestricted Stock Units · Derivative 2,949 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000176 · wf-form4_159138957133577.xml · derivative · entry 2

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,898

Underlying: Common Stock, $0.10 par value · 2,949 shares

Expires 2022-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:39 UTC Exercise / conversionCommon Stock, $0.10 par value 2,949 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000176 · wf-form4_159138957133577.xml · nonDerivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,358

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:40 UTC Exercise / conversionRestricted Stock Units · Derivative 2,949 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000177 · wf-form4_159138960535420.xml · derivative · entry 3

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,898

Underlying: Common Stock, $0.10 par value · 2,949 shares

Expires 2022-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:40 UTC Exercise / conversionCommon Stock, $0.10 par value 2,949 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000177 · wf-form4_159138960535420.xml · nonDerivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
June 03, 2020 Filed Jun 9, 2020 23:15 UTC
Eid JosephSVP,Head Glob. Medical Affairs
Exercise / conversionRestricted Stock Units · Derivative 2,154 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · derivative · entry 3

Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,463

Underlying: Common Stock, $0.10 par value · 2,154 shares

Expires 2023-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F4 · date: Due to an administrative error, this Form 4 was not timely filed.

F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020.

F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020.

F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020.

Read SEC document
June 03, 2020 Filed Jun 9, 2020 23:15 UTC
Eid JosephSVP,Head Glob. Medical Affairs
Tax withholdingCommon Stock, $0.10 par value 738 $60.21 $44,434.98
Disclosure

SEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 2

Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,861

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
June 03, 2020 Filed Jun 9, 2020 23:15 UTC
Eid JosephSVP,Head Glob. Medical Affairs
Exercise / conversionCommon Stock, $0.10 par value 2,154 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 1

Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020.

F2 · price: Each restricted stock unit converts into one share of common stock upon vesting.

Read SEC document
May 22, 2020 Filed May 26, 2020 21:17 UTC
Dubow AdamSVP,ChiefCompliance&EthicsOff.
SaleCommon Stock, $0.10 par value 3,200 $61.01 $195,232.00
Disclosure

SEC source: 0000014272-20-000173 · wf-form4_159052780720866.xml · nonDerivative · entry 1

Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,086.152

Read SEC document
May 19, 2020 Filed May 21, 2020 21:22 UTC
Schmukler Louis SEVP,Pres.,Glob.Prod. & Supply
SaleCommon Stock, $0.10 par value 25,000 $62.68 $1,567,000.00
Disclosure

SEC source: 0000014272-20-000171 · wf-form4_159009615262854.xml · nonDerivative · entry 1

Schmukler Louis S · CIK 0001530894 · EVP,Pres.,Glob.Prod. & Supply

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,777.466

F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.66 to $62.72, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
AHMED NADIMEVP and President, Hematology
Exercise / conversionRestricted Stock Units · Derivative 2,908 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · derivative · entry 4

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 2,908 shares

Expires 2020-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
AHMED NADIMEVP and President, Hematology
Tax withholdingCommon Stock, $0.10 par value 1,433 $60.26 $86,352.58
Disclosure

SEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · nonDerivative · entry 2

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,030

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
AHMED NADIMEVP and President, Hematology
Exercise / conversionCommon Stock, $0.10 par value 2,908 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 10,707 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 10,707 shares

Expires 2020-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
Vessey RupertEVP, Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 5,274 $60.26 $317,811.24
Disclosure

SEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,776

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:49 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 10,707 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.